✦ LIBER ✦

Etoposide, epirubicin and carboplatin in hormone-refractory prostate cancer

✍ Scribed by H. Fuse; Y. Muraishi; Y. Fujishiro; T. Katayama

Book ID: 110552876
Publisher: Springer Netherlands
Year: 1996
Tongue: English
Weight: 362 KB
Volume: 28
Category: Article
ISSN: 0301-1623
DOI: 10.1007/bf02550142

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral etoposide in the treatment of hormo

Oral etoposide in the treatment of hormone-refractory prostate cancer

✍ Maha H. Hussain; Kenneth J. Pienta; Bruce G. Redman; Glenn D. Cummings; Lawrence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

Effect of carboplatin on response and pa

Effect of carboplatin on response and palliation in hormone-refractory prostate cancer

✍ W. F. Jungi; Jürg Bernhard; Christoph Hürny; Shu-Fang Hsu Schmitz; Silvia Hansel 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 81 KB

Chemotherapy in hormone-refractory prost

Chemotherapy in hormone-refractory prostate cancer

✍ Ronald De Wit 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Ifosfamide, carboplatin and etoposide (I

Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer

✍ A. Y. Chang; L. Hui; R. Asbury; L. Boros; G. Garrow; J. Rubins 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 62 KB

Weekly epirubicin in patients with hormo

Weekly epirubicin in patients with hormone-resistant prostate cancer

✍ Petrioli, R; Fiaschi, A I; Pozzessere, D; Messinese, S; Sabatino, M; Marsili, S; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 115 KB

Monthly paclitaxel and carboplatin with

Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer

✍ Takehiko Segawa; Toshiyuki Kamoto; Hidefumi Kinoshita; Yasuharu Kunishima; Koji 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 378 KB